Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Psychol Assess. 2015 May 18;28(1):39–50. doi: 10.1037/pas0000142

Table 1.

Description of samples and measures used in the current study

Size Population FFM
Measure
BPD measure Validity Measures
Sample 1 358 undergraduate
students
NEO PI-R SCID-II P/Q SCID-II P/Q
Illicit Drug Use
Sample 2 350 undergraduate
students
NEO PI-R SCID II P/Q
PDQ-4+
MSI-BPD
BSI
CATS
DERS
Illicit Drug Use
Sample 3 3127 adult Australian
twins
NEO FFI PAI-BOR
Sample 4 1611 older adult
community
NEO PI-R SIDP-IV SIDP-IV
C-DIS-IV
M.I.N.I
Sample 5 107 adult outpatient:
general clinical
NEO PI-R SCID-II SCID-II
BSI
Illicit Drug Use
Sample 6 151 adult outpatient:
BPD (62%) and
MDD/DYS
(34%)
NEO PI-R SIDP-IV
PAI-BOR
SIDP-IV

Note: FFM = Five-Factor Model; BPD = Borderline Personality Disorder; MDD/DYS = Major Depressive Disorder/Dysthymia; NEO PI-R = NEO Personality Inventory-Revised; NEO FFI = NEO Five Factor Inventory; SCID-II P/Q – Structured Clinical Interview for DSM-IV Axis II Personality Disorders – Personality Questionnaire; PDQ-4+ = Personality Diagnostic Questionnaire-4+; MSI-BPD = McLean Screening Instrument for Borderline Personality Disorder; SIDP-IV = Structured Interview for DSM-IV Personality; SCID-II = Structured Clinical Interview for DSM-IV Axis II Personality Disorders; PAI-BOR = Personality Assessment Inventory – Borderline subscale; BSI = Brief Symptom Inventory; CATS = Child Abuse and Trauma Scale; DERS = Difficulties in Emotion Regulation Scale; C-DIS-IV = Computerized Diagnostic Interview Schedule screener; M.I.N.I. = MINI-International Neuropsychiatric Interview;